InvestorsObserver
×
News Home

Should You Add Iovance Biotherapeutics Inc (IOVA) Stock to Your Portfolio Friday?

Friday, November 24, 2023 11:21 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Add Iovance Biotherapeutics Inc (IOVA) Stock to Your Portfolio Friday?

A rating of 89 puts Iovance Biotherapeutics Inc (IOVA) near the top of the Healthcare sector according to InvestorsObserver. Iovance Biotherapeutics Inc's score of 89 means that it ranks higher than 89% of stocks in the sector. In addition, its overall score of 66 ranks it higher than 66% of all stocks.

Overall Score - 66
IOVA has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on IOVA!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 66 would rank higher than 66 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Iovance Biotherapeutics Inc Stock Today?

Iovance Biotherapeutics Inc (IOVA) stock is trading at $5.68 as of 11:15 AM on Friday, Nov 24, an increase of $0.28, or 5.19% from the previous closing price of $5.40. The stock has traded between $5.48 and $5.95 so far today. Volume today is light. So far 2,220,278 shares have traded compared to average volume of 6,637,920 shares. Click Here to get the full Stock Report for Iovance Biotherapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App